Jean-Michel Foidart
Founder bij MITHRA PHARMACEUTICALS S.A.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Stéphane Silvente | M | - |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | 6 jaar |
Stijn van Rompay | M | 48 |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | 5 jaar |
Christophe Maréchal | M | - | 7 jaar | |
Hugues Wallemacq | M | - |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | 3 jaar |
Philippe Lefèbvre | M | - |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | 6 jaar |
Christian Homsy | M | 65 | 1 jaar | |
Valérie Gordenne | F | 51 | 8 jaar | |
Gérard Tobelem | M | 76 |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | 6 jaar |
Maria Alvarez Gonzalez | F | - |
Belma Technologies SA
Belma Technologies SA Miscellaneous Commercial ServicesCommercial Services Belma Technologies SA is a Belgian company that specializes in biotechnological research and development. The company is based in Liege, Belgium. Belma Technologies was founded in 2015 by Brigitte Evrard, Maria Alvarez Gonzalez. | 9 jaar |
Inge Beernaert | M | - | 1 jaar | |
Fanny Rozenberg | F | - | - | |
Stijn Vlaminck | M | - | 3 jaar | |
Caroline Thielen | M | - |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | - |
Laurence Schyns | F | - | 3 jaar | |
Emile Loria | M | 74 |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | - |
Cedric Darcis | M | - | - | |
Benjamin Brands | M | - | 15 jaar | |
Pieter van Rompay | M | - |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | 5 jaar |
Jean-Manuel Fontaine | M | - | 11 jaar | |
Patrick Stragier | M | - |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | - |
Jacques Galloy | M | 53 | 1 jaar | |
Graham Dixon | M | 63 | 5 jaar | |
Didier Leballue | M | - |
Belma Technologies SA
Belma Technologies SA Miscellaneous Commercial ServicesCommercial Services Belma Technologies SA is a Belgian company that specializes in biotechnological research and development. The company is based in Liege, Belgium. Belma Technologies was founded in 2015 by Brigitte Evrard, Maria Alvarez Gonzalez. | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
François Fornieri | M | - | 23 jaar | |
Ajit Shetty | M | 77 | - | |
Patricia van Dijck | M | 59 | - | |
Christian Moretti | M | 78 | 2 jaar | |
Erik van den Eynden | M | 56 | 2 jaar | |
An Cloet | F | 53 | 2 jaar | |
Liesbeth Weynants | F | 53 | 2 jaar | |
Eric van Traelen | M | - | - | |
Marc. A. A. A. L Coucke | M | 59 | - | |
Christiane Malcorps | M | - | - | |
Maud Vanderthommen | F | - | 4 jaar | |
Alexandra Deschner | F | - | - | |
Patrick Kellens | M | - | 2 jaar | |
Sofie van Gijsel | F | - | - | |
Benoît Mathieu | M | - | 2 jaar | |
Frederik Vanvoorden | M | - | - | |
Rudi Meurs | M | - | - | |
Michaël Truyen | M | - | - | |
Jan van der Auwera | M | - | 7 jaar | |
Julie Dessart | F | - | - | |
Steven Peters | M | - | 2 jaar | |
Gaëtan Servais | M | 56 | 2 jaar | |
David Solomon | M | 63 | 1 jaar | |
Leon van Rompay | M | 75 | - | |
Amel Tounsi | M | 43 | 2 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
België | 48 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Jean-Michel Foidart
- Persoonlijk netwerk